Skip to main content
SpringerLink
Log in

Dapoxetine: a guide to its use in premature ejaculation

  • Drug and Profile Report
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig 1
Fig 2

References

  1. Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010 Feb 20; 57(5): 804–14

    Article  PubMed  Google Scholar 

  2. Hoy SM, Scott LJ. Dapoxetine: in premature ejaculation. Drugs 2010; 70(11): 1433–43

    Article  PubMed  CAS  Google Scholar 

  3. Priligy 30 and 60 mg film-coated tablets summary of product characteristics. Sollentuna: Janssen-Cilag AB, 2010 Feb

  4. McMahon C, Kim SW, Park NC, et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010 Jan; 7 (1 Pt 1): 256–68

    Article  PubMed  CAS  Google Scholar 

  5. Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006 Sep; 368(9539): 929–37

    Article  PubMed  CAS  Google Scholar 

  6. Buvat J, Tesfaye F, Rothman M, et al. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009 Apr; 55(4): 957–68

    Article  PubMed  CAS  Google Scholar 

  7. McVary KT, Rosen R, Ho K-F, et al. Effect of dapoxetine on intravaginal ejaculatory latency time in men with lifelong or acquired premature ejaculation [abstract no. 99]. J Sex Med 2006 Jan; 3Suppl. 1: 45. Plus poster presented at the 2005 Fall Meeting of the Sexual Medicine Society of North America; 2005 Nov 17–20; New York

    Google Scholar 

  8. Hellstrom WJ, Sharlip ID, Miloslavsky M. Efficacy of dapoxetine in men with self-rated very poor control over ejaculation [abstract no. 917]. J Urol 2006 Apr; 175(4 Suppl.): 297

    Google Scholar 

  9. Shabsigh R, Broderick GA, Miloslavsky M, et al. Dapoxetine has long-term efficacy in the treatment of premature ejaculation [abstract no. 918]. J Urol 2006 Apr; 175(4 Suppl.): 297–8

    Google Scholar 

  10. Kaufman JM, Rosen RC, Mudumbi RV, et al. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. BJU Int 2009 Mar; 103(5): 651–8

    Article  PubMed  CAS  Google Scholar 

  11. McMahon C, Althof S, Kaufman J, et al. Efficacy and safety of dapoxetine for premature ejaculation: integrated analysis of 5 phase 3 trials [abstract no. PD-068]. J Sex Med 2009; 6Suppl. 2: 69–70. Plus oral presentation at the Joint Congress of the European and International Societies for Sexual Medicine; 2008 Dec 7–11; Brussels

    Google Scholar 

  12. Shabsigh R, Tesfaye F. Low incidence of sexual side effects with dapoxetine (DPX) for the treatment of premature ejaculation [abstract no. 78]. J Sex Med 2008; 5Suppl. 1: 31. Plus poster presented at the Winter Scientific Meeting of the Sexual Medicine Society of North America; 2007 Dec 6–9; Chicago (IL)

    Google Scholar 

  13. Levine SB, Casey RW, Mudumbi RV, et al. Evaluation of withdrawal effects with dapoxetine in the treatment of premature ejaculation (PE) [abstract no. 82]. J Sex Med 2007; 4Suppl. 1: 91. Plus poster presented at the Fall Meeting of the Sexual Medicine Society of North America; 2006 Nov 2–5; Las Vegas (NV)

    Google Scholar 

  14. Giuliano F, Levine SB, Buvat J, et al. Lack of withdrawal syndrome or effects on anxiety with dapoxetine (DPX) for the treatment of premature ejaculation: results from 2 phase III trials. Eur Urol Suppl 2008 Mar; 7(3): 187. Plus poster presented at the 23rd Annual Congress of the European Association of Urology; 2008 Mar 26–29; Milan

    Article  Google Scholar 

  15. Shabsigh R, Broderick G, Miloslavsky M, et al. Long-term safety and tolerability of dapoxetine for the treatment of men with premature ejaculation [abstract no. 174]. Eur Urol Suppl 2006 Apr; 5(2): 66. Plus poster presented at the 2006 Annual Congress of the European Association of Urology; 2006 Apr 5–8; Paris

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dapoxetine: a guide to its use in premature ejaculation. Drugs Ther. Perspect 27, 1–4 (2011). https://doi.org/10.2165/11206280-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11206280-000000000-00000

Keywords

Search

Navigation